跳至主要内容
临床试验/JPRN-UMIN000026084
JPRN-UMIN000026084已完成未知

Autologous peripheral blood stem cell transplantation using Thiotepa, Carboplatin and Etoposide conditioning in patients with relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT) - Autologous peripheral blood stem cell transplantation using Thiotepa, Carboplatin and Etoposide conditioning in patients with relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)

agoya University Graduate School of Medicine0 个研究点目标入组 10 人开始时间: 2017年5月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 19years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1 active double cancer 2 active infection needed systemic therapy 3 body temperature more than or equal to 38 degrees C 4 in pregnancy, breastfeeding, strong possibility of pregnancy 5 positive in HBs antigen, HBV-DNA, HCV antibody 6 positive in HIV antibody(no measurement is OK) 7 inadequate for other reason by doctor's assessment

研究者

发起方
agoya University Graduate School of Medicine

相似试验

Autologous peripheral blood stem cell... | 临床试验